Sudan Loganathan
Stock Analyst at Stephens & Co.
(3.26)
Main Sectors:
Top Industries:
17 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CCCC C4 Therapeutics | Reiterates: Overweight | 6 6 | 2.23 | 169.06% | 3 | Sep 22, 2025 | |
ARVN Arvinas | Maintains: Overweight | 16 14 | 8.27 | 69.29% | 2 | Sep 18, 2025 | |
IDYA IDEAYA Biosciences | Reiterates: Overweight | 45 45 | 26.83 | 67.72% | 3 | Sep 9, 2025 | |
NRIX Nurix Therapeutics | Reiterates: Overweight | 30 30 | 8.93 | 235.95% | 4 | Jul 10, 2025 | |
EXEL Exelixis | Upgrades: Overweight | 29 60 | 39.04 | 53.69% | 5 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 10.74 | 132.77% | 3 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 150 135 | n/a | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 5 5 | n/a | n/a | 4 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 30 30 | 11.59 | 158.84% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 33 | 19.52 | 69.06% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 8 | 3.65 | 119.18% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 7.4 | 102.7% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 56.25 | 6.67% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.59 | 214.47% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.14 | 507.48% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 100 100 | 8.87 | 1027.4% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 2.48 | 706.45% | 1 | May 14, 2024 |